Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2013
A rationally designed A34R mutant oncolytic poxvirus: improved efficacy in peritoneal carcinomatosisPragatheeshwar Thirunavukarasu, Magesh Sathaiah, Michael C Gorry, et al.
Journal of Cellular Biochemistry|July 28, 2015
TRAIL-Induced Caspase Activation Is a Prerequisite for Activation of the Endoplasmic Reticulum Stress-Induced Signal Transduction PathwaysDae-Hee Lee, Ki Sa Sung, Zong Sheng Guo, et al.
Annals of Surgical Oncology|February 12, 2021
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic MalignanciesChigozirim N Ekeke, Kira L Russell, Kyla Joubert, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 2, 2018
Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 BlockadeStacy J Kowalsky, Zuqiang Liu, Mathilde Feist, et al.
Journal for Immunotherapy of Cancer|January 11, 2019
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolyticsZong Sheng Guo, Binfeng Lu, Zongbi Guo, et al.
Cancer Immunology, Immunotherapy : CII|February 4, 2021
IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunityMin Yang, Esther Giehl, Chao Feng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2020
Synergistic Combination of Oncolytic Virotherapy and Immunotherapy for GliomaBingtao Tang, Zong Sheng Guo, David L Bartlett, et al.
Journal for Immunotherapy of Cancer|March 27, 2020
Oncolytic vaccinia virus delivering tethered IL-12 enhances antitumor effects with improved safetyYan Ge, Haiyan Wang, Jinghua Ren, et al.
Pageof 5